NATCOPHARMPharmaceuticals

Natco Pharma LtdFinancial Ratios & Key Metrics

974.20
+0.51%
P/E Ratio10.50xIndustry: 31.77x
ROE28.00%Return on equity
ROCE32.78%Return on capital
Debt/Equity0.03Low debt
💎

Valuation & Profitability

P/E Ratio
10.50x
Industry Average P/E
31.77x
Dividend Yield
0.66%
Market Cap
₹16.16K (Cr)
Sales Growth 5Y
18.26%
Profit Growth 5Y
33.27%
EPS Growth 5Y
33.70%
OPM 5Y Avg
38.03%
📉

Price Returns

1 Month
+10.16%
3 Months
+4.34%
6 Months
+5.15%
1 Year
-34.34%
52W Low
727
Current
974
52W High
1059
74% of 52-week range — Near highs
🔬

Technical Indicators

43RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
904
▲ Price above SMA 50 — Bullish
SMA 200
891
▲ Long-term uptrend
Volume Signal
22% of avg
Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.